Resistance of Trypanosoma cruzi to blood clearance induced by acute-phase immune mouse serum.
To investigate functional changes in Trypanosoma cruzi parasites induced during their interaction with the vertebrate host, we compared the blood clearance profiles of blood forms isolated from infected normal mice (Reg-Tc) or from infected mice immunodepressed after treatment with cyclophosphamide (Cy-Tc). Parasite blood numbers were measured at various time intervals in animals injected intravenously (i.v.) with 1-2 x 10(6) T. cruzi of either isolate. In the absence of added immune sera (spontaneous clearance), Reg-Tc and Cy-Tc were cleared from blood at similar rates. However, when acute immune mouse serum (Ac-IMS) was injected i.v. 2 min after inoculation of parasites, a significant proportion of Cy-Tc only was cleared from the blood an hour later, whereas Reg-Tc were not, their clearance profile being identical to that observed in mice injected with normal mouse serum. Cy-Tc susceptibility to Ac-IMS was not the result of a toxic effect of cyclophosphamide over T. cruzi as parasites recovered from animals immunodepressed by irradiation before infection were cleared similarly by acute serum. Contrary to Ac-IMS, chronic immune mouse serum induced similar rates of disappearance of Reg-Tc and Cy-Tc from blood. Our results suggest the occurrence of T. cruzi selection or modification during the acute phase, which leads to an increased parasite resistance to the clearance properties of acute-phase antibodies.
Alvarez
J M
JM
Departamento de Imunologia, Universidade de São Paulo, Brazil.
Marinho
C R
CR
Oshima
A
A
Guimaraes
L
L
Menezes
H
H
D000210:Acute-Phase Reaction / Q000097:blood / Q000276:immunology*; D000704:Analysis of Variance; D000818:Animals; D014355:Chagas Disease / Q000097:blood / Q000276:immunology*; D003520:Cyclophosphamide; D005260:Female; D007106:Immune Sera / Q000276:immunology*; D007165:Immunosuppression Therapy; D051379:Mice; D014349:Trypanosoma cruzi / Q000276:immunology*
D007106:Immune Sera; D003520:Cyclophosphamide